¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽɺÎÀüÇÐȸ Á¦43Â÷ Ãß°è Çмú´ëȸ(Heart Failure Seoul 2021) 2ÀÏÂ÷ : 2021-09-17

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѽɺÎÀüÇÐȸ Á¦43Â÷ Ãß°è Çмú´ëȸ(Heart Failure Seoul 2021) 2ÀÏÂ÷ : 2021-09-17
±³À°ÀÏÀÚ : 2021-09-17
±³À°Àå¼Ò : ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5Ãþ ±×·£µåº¼·ë  
±³À°ÁÖÁ¦ : ´ëÇѽɺÎÀüÇÐȸ Á¦43Â÷ Ãß°è Çмú´ëȸ(Heart Failure Seoul 2021) 2ÀÏÂ÷
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѽɺÎÀüÇÐȸ  
´ã´çÀÚ : ¹éÁöÀº
¿¬¶ôó : 02-3275-5335  
À̸ÞÀÏ : kshf4@kshf.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 8 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 70,000¿ø      
ºñ°í ±³¼ö: 70,000¿ø, ÀϹÝÀÇ: 30,000¿ø, Àü°øÀÇ, °£È£»ç, 65¼¼ ÀÌ»ó, Çлý, ±âŸ(ÀÌ¿Ü ÀÇ·áÁ¾»çÀÚ): ¹«·á      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 09:00~09:20 Introduction of ESC (or HFA) Educational Program  Ewa Anita Jankowska(Wroclaw Medical University) 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 09:20~09:35 Current Status and Future Perspective of Educational Program for Cardiologist in Korea  ¹ÚÈñ³²(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 09:35~09:50 Setting Up of Early Career as a HF Specialist  ±è°æÈñ(ÀÎõ¼¼Á¾º´¿ø) 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 09:50~10:20 New HFpEF Diagnosis Concept. Is the Classiffication based on Ejection Fraction Kept on?  Andrew Coats(Univ of Warwick UK) 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 10:20~10:50 Novel or Revisit of Pharmacological Treatment of HFpEF  Stefan D. Anker(Charite Campus Virchow Clinic Germany) 
Åä·Ð 09-17 ±×·£µåº¼·ë 10:50~11:10 Discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
È޽Ġ09-17 ±×·£µåº¼·ë 11:10~11:20 Short Coffee Break  () 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 11:20~11:35 Practical Management of ECMO in aborted Sudden Cardiac Death  ±è¹Î¼®(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 11:35~11:50 Start ECMO in Left Heart Decompression: When, How ?  À̼±±â(ÇѸ²ÀÇ´ë) 
Åä·Ð 09-17 ±×·£µåº¼·ë 11:50~12:00 Discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
½Ä»ç 09-17 ±×·£µåº¼·ë 12:00~13:00 Lunch  () 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 13:00~14:00 Brightening Abstract Presentation (I)  () 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 14:00~14:15 Utilization of Marginal Donors in Heart Transplantation  Jon A Kobashigawa(Cedars-Sinai Medical Center USA) 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 14:15~14:30 Current Status of Heart Transplantation and LVAD in Korea  ÃÖÁø¿À(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 14:30~14:45 The Right Ventricle and LVAD Therapy  Mandeep R Mehra(Harvard Univ. USA) 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 14:45~15:00 Palliative Management in End Stage HF Patients  À̼ö¿ë(ºÎ»êÀÇ´ë) 
Åä·Ð 09-17 ±×·£µåº¼·ë 15:00~15:20 Discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
È޽Ġ09-17 ±×·£µåº¼·ë 15:20~15:30 Short Coffee Break  () 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 15:30~15:45 Initial Phenotyping and Therpeutic Decision Making in HFpEF  ÃÖÁ¤Çö(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 15:45~16:00 Echocardiography for CIED  ±è¿ëÁø(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 16:00~16:15 Decision Making in Critically Ill Patients  ±è´ëÈñ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 16:15~16:30 The Use of Echocardiography in Post Heart Transplantation  ½ÉÁö¿µ(¿¬¼¼ÀÇ´ë) 
Åä·Ð 09-17 ±×·£µåº¼·ë 16:30~17:00 Discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
È޽Ġ09-17 ±×·£µåº¼·ë 17:00~17:10 Short Coffee Break  () 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 17:10~17:25 Gender specific HF treatment strategy  ±èÇзÉ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 17:25~17:40 RFA of atrial fibrillation and single nucleotide polymorphism  ÃÖÁ¾ÀÏ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 17:40~17:55 Role of precision medicine in pulmonary hypertension  Á¤¿íÁø(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 17:55~18:10 Emerging Roles of Biomarkers in Heart Failure  Á¶µ¿Çõ(¿¬¼¼¿øÁÖÀÇ´ë) 
Åä·Ð 09-17 ±×·£µåº¼·ë 18:10~18:40 Discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽɺÎÀüÇÐȸ Á¦43Â÷ Ãß°è Çмú´ëȸ(Heart Failure Seoul 2021) 2ÀÏÂ÷ : 2021-09-17""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѽɺÎÀüÇÐȸ Á¦43Â÷ Ãß°è Çмú´ëȸ(Heart Failure Seoul 2021) 3ÀÏÂ÷ : 2021-09-18
´ÙÀ½±Û ´ëÇѽɺÎÀüÇÐȸ Á¦43Â÷ Ãß°è Çмú´ëȸ(Heart Failure Seoul 2021) 1ÀÏÂ÷ : 2021-09-16
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
219 ÀÎõ Á¦3ȸ ÀÎÇϴ뺴¿ø ¼Ò¾Æû¼Ò³â°ú ±³À°°­Á : 2018-09-08 0 844 2018-07-28
218 ¼­¿ï Á¦ 19ȸ ´ëÇÑÅõ¼®Çùȸ Ãß°è ½ÉÆ÷Áö¿ò : 2018-09-08 1 673 2018-07-28
217 ¼­¿ï ´ëÇѽÉÀåÇÐȸ EP Review Course 2018-2 : 2018-09-08 0 942 2018-07-28
216 ÀüºÏ 2018³â Á¦29ȸ ´ëÇÑ°£ÇÐȸ Ãß°è Single Topic Symposium ¹× ÃÊÀ½ÆÄ Hands-on : 2018-09-08 0 371 2018-07-28
215 ÀÎõ 2018³â ±¹Á¦¼º¸ðº´¿ø °³¿øÀÇ ¿¬¼ö°­Á : 2018-09-08 0 538 2018-07-28
214 ÀÎõ °¡ÃµÀÇ´ë±æº´¿ø È£½ºÇǽº ¿ÏÈ­ÀÇ·á Á¤Âø°ú È®´ë¸¦ À§ÇÑ ÀÎõÁö¿ª¾Ï¼¾ÅÍ ½ÉÆ÷Áö¿ò : 2018-09-08 0 1,210 2018-07-28
213 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø ¾È°ú ±Ý¿ä¼¼¹Ì³ª : 2018-09-07 0 303 2018-07-28
212 °æ±â ¸íÁöº´¿ø The 3nd MYONGJI INTERNATIONAL LIVER SYMPOSIUM : 2018-09-07 0 387 2018-07-28
211 ¼­¿ï 2018³âµµ ´ëÇѺñ¸¸ÇÐȸ ±¹Á¦Çмú´ëȸ(ICOMES 2018) - 09/07 : 2018-09-07 0 468 2018-07-28
210 ¼­¿ï 2018³â ¼­¿ï¾Æ»êº´¿ø ¾Ïº´¿ø ½ÉÆ÷Áö¾ö : 2018-09-07 0 484 2018-07-28
209 ¼­¿ï ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ 2018³â ¹Î°£¡¤°ø°øÇù·Â(PPM) ±¹°¡°áÇÙ°ü¸®»ç¾÷ Æò°¡´ëȸ : 2018-09-07 0 551 2018-07-28
208 ´ë±¸ ±¹¸³ÀÇ·á¿ø °ø°øÀÇ·á Consensus conference(4Â÷: °æ»óÁ¦ÁÖ±Ç) : 2018-09-07 0 590 2018-07-28
207 ¼­¿ï 2018³â ½ÅÁ¾ ¹× »ý¹°Å×·¯°¨¿°º´ ´ëÀÀÀü¹®¿ä¿ø ±³À°[»çÀüµî·Ï Çʼö] : 2018-09-07 0 279 2018-07-28
206 ¼­¿ï °í·Á´ëÇб³¾È¾Ïº´¿ø ÀÏÂ÷ ÀÇ·áÁø°ú ÇÔ²²ÇÏ´Â ½É¹æ¼¼µ¿ÀÇ Ä¡·á : 2018-09-07 0 525 2018-07-28
205 ¼­¿ï ´ëÇÑÀÇ»çÇùȸ [Á¦27±â ÀÇ·áÁ¤Ã¥ÃÖ°íÀ§°úÁ¤] ÀÇ·á»ç°í¿Í Á¶Á¤ ÁßÀç / ¼³¸íÀǹ« : 2018-09-06 0 373 2018-07-28
1361 | 1362 | 1363 | 1364 | 1365 | 1366 | 1367 | 1368 | 1369 | 1370
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷